Telithromycin inhibition of protein synthesis and 50S ribosomal subunit formation in Streptococcus pneumoniae cells

Current Microbiology

Volumn 45, Issue 5, 2002, Pages 328-333

  Champney, W Scott ^a   Pelt, Jennifer ^a  

^a East Tennessee State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIBOSOME RNA; RNA 50S; TELITHROMYCIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; KETOLIDE; MACROLIDE; PROTEIN SYNTHESIS INHIBITOR; URIDINE;

ANIMAL CELL; ARTICLE; BACTERIAL CELL; CELL GROWTH; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; IC 50; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; RIBOSOME SUBUNIT; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; COMPARATIVE STUDY; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; METABOLISM; RIBOSOME;

ANIMALIA; BACTERIA (MICROORGANISMS); POSIBACTERIA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; INHIBITORY CONCENTRATION 50; KETOLIDES; MACROLIDES; PROTEIN SYNTHESIS INHIBITORS; RIBOSOMES; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; URIDINE;

EID: 0036833425     PISSN: 03438651     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00284-002-3710-0     Document Type: Article

References (38)

1. Amabile-Cuevas CF, Cardenas-Garcia M, Ludgar M (1995) Antibiotic resistance. Am Sci 83:320-329
2. Appelbaum PC (1992) Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 15:77-83
3. Barry AL, Fúchs PC, Brown SD (1998) Antipneumococcal activities of a ketolide (HMR3647), a streptogramin (Quinupristin-dalfopristin), a macrolide (erythromycin) and a lincosamide (clindamycin). Ahtimicrob Agents Chemother 42:945-946
4. B resistance phenotype. J Antimicrob Chemother 40:85-90
5. Boswell FJ, Andrews JM, Ashby JP, Fogerty C, Brenwald NP, Wise R (1998) The in-vitro activity of HMR 3647, a new ketolide antimicrobial agent. J Antimicrob Chemother 42:703-709
6. Bryskier A, Agourides C, Chantot JF (1997) Ketolides: new semi-synthetic 14-membered macrolides. In: Zinner SH, Young LS, Acar JF, Neu HC (eds) Expanding indications for the new macrolides, azalides and streptogramins. New York: Marcel Dekker, pp 39-50
7. Champney WS (1999) Macrolide antibiotic inhibition of 50S ribosomal subunit formation in bacterial cells. Recent Res Dev Antimicrob Agents Chemother 3:39-58
8. Champney WS (2001) Bacterial ribosomal subunit synthesis: a novel antibiotic target. Curr Drug Targets 1:125-133
9. Champney WS, Tober CL (1998) Inhibition of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells by eleven different ketolide antibiotics. Curr Microbiol 37:418-425
10. Champney WS, Tober CL (2001) Structure-activity relationships for six ketolide antibiotics. Curr Microbiol 42:203-210
11. Champney WS, Tober CL, Burdine R (1998) A comparison of the inhibition of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells by nine different macrolide antibiotics. Curr Microbiol 37:412-417
12. Chopra I, Hodgson J, Metcalf B, Poste G (1997) The search for antimicrobial agents effective against bacteria resistant to multiple antibiotics. Antimicrob Agents Chemother 41:497-503
13. Chu DT, Plattner JJ, Katz L (1996) New directions in antibacterial research. J Med Chem 39:3853-3874
14. Copobianco JO, Cao ZS, Shortridge VD, Ma Z, Flamm RK, Zhong P (2000) Studies of the novel ketolide ABT-773: transport, binding to ribosomes, and inhibition of protein synthesis in Streptococcus pneumoniae. Antimicrob Agents Chemother 44:1562-1567
15. Davies TA, Dewasse BE, Jacobs MR, Applebaum PC (2000) In vitro development of resistance to telithromycin (HMR3647), four macrolides, clindamycin, and prinstinamycin in Streptococcus pneumoniae. Antimicrob Agents Chemother 44:414-417
16. Denis A, Agouridas C, Auger J-M, Benedetti Y, Bonnefoy A, Bretin F, et al. (1999) Synthesis and antibacterial activity of HMR3647 a new ketolide highly potent against erythromycin-resistant and susceptible pathogens. Bioorgan Med Chem Lett 9:3075-3080
17. Douthwaite S, Hansen LH, Mauvais P (2000) Macrolide-ketolide inhibition of MLS-resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNA. Mol Microbiol 36:183-193
18. Ednie LM, Jacobs MR, Appelbaum PC (1997) Comparative antianaerobic activities of the ketolides HMR 3647 (RU66647) and HMR 3004 (RU 64004). Antimicrob Agents Chemother 41:2019-2022
19. Feikin DR, Schuchat A, Kolczak M, Barrett NL, Harrison LH, Lefkowitz L, et al. (2000) Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health 90:223-229
20. Felmingham D (2001) Microbiological profile of telithromycin, the first ketolide antimicrobial. Clin Microb Infect 7:2-10
21. Fernandez-Roblas R, Calvo R, Esteban J, Bryskier A, Soriano F (1999) The bactericidal activities of HMR 3004, HMR 3647 and erythromycin against gram-positive bacilli and development of resistance. J Antimicrob Chemother 43:285-289
22. Giovanetti E, Montanari MP, Varaldo PE (2000) In vitro activity of ketolides telithromycin and HMR 3004 against Italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility. J Antimicrob Chemother 46:905-908
23. Gold HS, Moellering RC (1996) Antimicrobial-drug resistance. New England J Med. 335:1445-1453
24. Jett BD, Hatter KL, Huycke M, Gilmore MS (1997) Simplified agar plate method for quantifying viable bacteria. BioTech 23:648-650
25. Malathum K, Coque TM, Singh KV, Murray BE (1999) In vitro activities of two ketolides, HMR 3647 and HMR 3004, against gram-positive bacteria. Antimicrob Agents Chemother 43:930-936
26. Miller JH (1972) Experiments in molecular genetics. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, pp 466
27. Nakayama I (1984) Macrolides in clinical practice. In: Omura S (ed) Macrolide antibiotics. Orlando, FL: Academic Press, pp 261-300
28. Pankuch GA, Visalli MA, Jacobs MR, Appelbaum PC (1998) Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared to 17 other agents. Antimicrob Agents Chemother 42:624-630
29. Reinert RR (1997) Antibiotic resistance in Streptococcus pneumoniae. Biospekrum 1997:27-30
30. Reinert RR, Bryskier A, Lutticken R (1998) In vitro activities of the new ketolide antibiotics HMR3004 and HMR3647 against Streptococcus pneumonia in Germany. Antimicrob Agents Chemother 42:1509-1511
31. Roblin PM, Hammerschlag MR (1998) In vitro activity of a new ketolide, HMR3647, against Chlamydia pneumoniae. Antimicrob Agents Chemother 42:1515-1516
32. Saez-Nieto JA, Vasquez JA (1999) In vitro activity of ketolides HMR 3647 and HMR 3004, levofloxacin, and other quinolones and macrolides against Neisseria ssp. and Moraxella catarrthalis. Antimicrob Agents Chemother 43:983-984
33. Usary J, Champney WS (2001) Erythromycin inhibition of 50S ribosomal subunit formation in Escherichia coli cells. Mol Microbiol 40:951-962
34. Whitney CG, Farley MM, Hadler J, Harrison LH, Lexau C, Reingold A, et al. (2000) Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. New Engl J Med 343:1917-1924
35. Williams JD, Sefton AM (1993) Comparison of macrolide antibiotics. J Antimicrob Chemother 31C:11-26
36. Wootton M, Bowker KE, Janowska A, Holt HA, MacGowan AP (1999) In-vitro activity of HMR 3647 against Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and β-haemolytic streptococci. J Antimicrob Chemother 44:445-453
37. Zarazaga M, Saenz Y, Portillo A, Tenorio C, Ruez-Larrea F, Campo RD, Baquero F, Torres C (1999) In vitro activity of ketolide HMR3647, macrolides, and other antibiotics against Lactobacillus, Leuconostoc, and Pedicoccus isolates. Antimicrob Agents Chemother 43:3039-3041
38. Zuckerman JM, Kaye KM (1995) The newer macrolides. Azithromycin and clarithromycin. Infect Dis Clin N Am 9:731-745